Recurrent pterygium resection associated to fibrin membrane graft: report of two cases

Recurrent pterygium resection associated to fibrin membrane graft: report of two cases

ABSTRACT We propose a novel surgical technique in cases of aggressive recurrent pterygium non-subsidiary of treatment with conjunctival autografts or antimetabolites. Two presented cases were treated with surgical excision and a sutured plasma rich in growth factors membrane (mPRGF) followed by rich...

Full description

Bibliographic Details
Main Authors: Isabel Mogollón Giralt, Ana Boto de los Bueis, Almudena del Hierro Zarzuelo, José Vicente Dabad Moreno, Rafael Montejano Milner, Borja de la Sen Corcuera
Format: Article
Language:English
Published: Sociedade Brasileira de Oftalmologia 2021-07-01
Series:Revista Brasileira de Oftalmologia
Subjects:
Pterygium
Recurrence
Platelet-rich fibrin
Platelet-rich plasma
Ophthalmic solutions
Tissue engineering
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802021000200146&tlng=en
Description
Summary:ABSTRACT We propose a novel surgical technique in cases of aggressive recurrent pterygium non-subsidiary of treatment with conjunctival autografts or antimetabolites. Two presented cases were treated with surgical excision and a sutured plasma rich in growth factors membrane (mPRGF) followed by rich in growth factors (PRGF) eye drops treatment. After surgery, dexamethasone, tobramycin and PRGF eye drops were prescribed for 6 weeks. After a 12-month and 3-year post-surgical follow-up respectively, treated eyes with mPRGF did not present relapse, and visual acuity improved in both cases. No ocular complications, pain, eye discomfort nor other symptoms were observed. The combined use of PRGF eye drops and mPRGF seems an effective and safe therapy for recurrent pterygium.
ISSN:1982-8551

Similar Items